Fermer le menu

Member of Lyonbiopole


A German family-owned company, founded in 1885, Boehringer Ingelheim is the first independent pharmaceutical group in the world. It employs more than 53,000 people across 130 countries.

In France, Boehringer Ingelheim is present through research and development activities, production and provision of therapeutic solutions for human and animal health. With 2,300 employees spread across 9 sites, the laboratory has a strong footprint throughout the country, particularly in the Lyon area, the group's center of gravity in France. Our French head office is located in Lyon Gerland and we have 2 research sites in Greater Lyon (Lyon Porte des Alpes and Saint-Vulbas) as well as 3 production sites (Lentilly, Saint-Priest and Jonage).

Thanks to its expertise, Boehringer Ingelheim contributes to consolidating the role of the Lyon region as a leading ecosystem in the field of life sciences. As an example, in 2022 we committed 30 million euros to found the Aurobac joint venture (together with BioMérieux and Evotec), intended to find innovative ways to fight antimicrobial resistance.

For more information, please visit www.boehringer-ingelheim.fr or www.boehringer-ingelheim.com


Strategic application domain: Veterinary Medicine

Application market: Cardiology, Infectious Diseases, Veterinary medicine

Type of activity: Diagnostics, Therapeutics, Pharma or Biotech

Technologies: Vaccine, Others

Created on july 1st, 1983 - 2300 employees



29 avenue Tony Garnier 69007 Lyon



Vous devez être connecté et membre de Lyonbiopôle pour voir les contacts.